Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for: September 14, 2011

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Incivek	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Required
Victrelis	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Natroba	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Xarelto	New Drug Initial Review	Remove Prior Approval Requirement	Preferred and Require Prior Approval
Tradjenta	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Moxeza	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Required

Footer